Public-private Collaborations and Partnerships in Stratified Medicine
Making Sense of New Interactions
Published in: New Biotechnology, v. 29, no. 6, Sep. 2012, p. 732-740
Posted on RAND.org on September 01, 2012
The field of personalised or stratified medicine is evolving alongside the formation of a plethora of public-private partnerships. Such collaborations are at the core of the set of new life sciences policies in the UK, but the rationale and basis for collaboration remains unclear and there is little indication in policy documents of clear boundaries for them. An article in the journal New Biotechnology discusses some of the drivers and dynamics of these collaborations.
Research conducted by
This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.